Clinical Trials on Right Ventricular Outflow Tract Stenosis in Hong Kong

Total 6 results

The University of Hong Kong

Unknown

Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction in Coronavirus Disease 2019 (COVID19) Survivors

COVID-19

Hong Kong
Duk-Woo Park, MD
CardioVascular Research Foundation, Korea; Daiichi Sankyo Korea Co., Ltd.

Completed

Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement (ADAPT-TAVR)

Aortic Valve Stenosis

Taiwan, Hong Kong, Korea, Republic of
Vascular Innovations Co. Ltd.
MedPass International

Active, not recruiting

A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve

Aortic Valve Stenosis

New Zealand, Hong Kong, Thailand, Greece, Lithuania, Poland
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

The Asian Transcatheter Aortic Valve Replacement Registry (Asian TAVR)

Aortic Valve Stenosis | Aortic Diseases

Korea, Republic of, China, Taiwan, Japan, Singapore
Actelion

Terminated

A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging (RESTORE)

Pulmonary Arterial Hypertension

Germany, Korea, Republic of, Israel, Singapore, United States, Russian Federation, Brazil, Netherlands, Malaysia, Saudi Arabia, United Kingdom, Hong Kong, France, United Arab Emirates, Argentina
Actelion

Completed

REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension (REPAIR)

Pulmonary Arterial Hypertension

United States, Israel, France, Netherlands, Malaysia, Germany, Australia, United Kingdom, Hong Kong, Italy, Russian Federation, Singapore

Clinical Trials on Right Ventricular Outflow Tract Stenosis in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations